Title: Professor of Molecular Medicine
Company: The University of Texas Health Science Center at Houston
Location: Missouri City, Texas, United States
Ba-Bie Teng, PhD, adjunct professor of molecular medicine at The University of Texas Health Science Center at Houston, has been recognized by Marquis Who’s Who Top Educators for dedication, achievements, and leadership in the field of health care academia.
With several decades of experience to her credit, Dr. Teng has cultivated a fulfilling career in the field of scientific and medical research and education. Specializing in gene therapy and medical procedures pertaining to atherosclerosis and lipid metabolism, she has served as an adjunct professor of molecular medicine at The University of Texas Health Science Center at Houston since 2021. She originally joined the institution in 2013 as a professor in the research center for human genetics, as part of the school’s Institute of Molecular Medicine, where she operated until 2020.
Adjacent to her primary endeavors, Dr. Teng has also worked with the M.D. Anderson UTHealth Graduate School of Biomedical Sciences as a faculty member since 2017. Furthermore, since 2000, she has excelled in a similar role at the W.M. Keck Center for Cancer Therapies, as part of The University of Texas MD Anderson Cancer Center. She also continues in her numerous scholarly endeavors, having authored numerous articles and served on the editorial boards of several academic journals for many years. Likewise, Dr. Teng is a fellow of the American Heart Association and a member of the American Society of Gene and Cell Therapy and the International Atherosclerosis Society.
At the onset of her vocational journey, Dr. Teng served as a research associate and assistant professor in the department of medicine at the University of Chicago from 1989 to 1992. Prior to entering her field, she pursued her own formal education, originally earning a Bachelor of Science at the National Chung Hsing University in her native home of Taiwan in 1970. She ultimately achieved a PhD in experimental medicine at McGill University in 1987. In addition to her academic credentials, Dr. Teng completed a postdoctoral fellowship with the division of molecular medicine at a clinical research center in London, England, between 1987 and 1989.
To commemorate her accomplishments in the field, Dr. Teng has been recognized with numerous accolades throughout her career. Chief among her honors include both an Established Investigator Award from the American Heart Association and first prize at her university’s Molecular Pathology Conference in 2002. In light of her fulfilling career, she has largely attributed her success to the guidance and encouragement of her mentors, especially Allan David Sniderman, her PhD advisor. Accounting for her achievements, Dr. Teng is particularly proud of her work at the University of Chicago, where she completed the cloning process of an RNA editing enzyme gene, which allowed her to solve a quandary pertaining to lipid metabolism.
For more information, please visit:
LinkedIn
Press Release
Contact Dr. Teng:
